Similarly, PEDF offers anti-angiogenic and anti-inflammatory effects that may be useful in wet AMD, and a combination treatment of AAV-delivered PEDF with a microRNA to inhibit VEGF successfully reduced choroidal neovascularization in a mouse model of AMD.107. This evidence concerns the gene SERPINF1 and wet macular degeneration.